|
|
| Line 55: |
Line 55: |
| | [[Non-Hodgkin lymphoma]] | | | [[Non-Hodgkin lymphoma]] |
| |- | | |- |
| | ''DA-EPOCH''' | | | '''DA-EPOCH''' |
| | Dose-adjusted [[Etopiside]], [[prednisone]], [[vincristine]] (Oncovin), [[Cyclophosphamide]] and doxorubicin | | | Dose-adjusted [[Etopiside]], [[prednisone]], [[vincristine]] (Oncovin), [[Cyclophosphamide]] and doxorubicin |
| | Newly diagnosed, aggressive [[non-Hodgkin lymphoma]] | | | Newly diagnosed, aggressive [[non-Hodgkin lymphoma]] |
| | |- |
| | | '''DHAP'''' |
| | | Dexamethasone, cytarabine (high-dose ARA-C), cisplatin |
| | | Recurrent or refractory [[non-Hodgkin lymphoma]] |
| |- | | |- |
| | '''EC''' | | | '''EC''' |
| Line 66: |
Line 70: |
| | [[Epirubicin]], [[cisplatin]], [[fluorouracil]] | | | [[Epirubicin]], [[cisplatin]], [[fluorouracil]] |
| | [[Gastric cancer]] and [[oesophageal cancer]] | | | [[Gastric cancer]] and [[oesophageal cancer]] |
| | |- |
| | | '''ESHAP''' |
| | | [[Etopiside]], methylprednisolone (Solu-medrol), cytarabine (ARA-C), cisplatin |
| | | Relapsed or refractory [[non-Hodgkin lymphoma]] |
| | |- |
| | | '''FN-D''' |
| | | Fludarabine, mitoxantrone (Novantrone), dexamethasone |
| | | Recurrent or refractory indolent [[non-Hodgkin lymphoma]] |
| |- | | |- |
| | '''[[FOLFOX]]''' | | | '''[[FOLFOX]]''' |
| | [[Fluorouracil]], [[leucovorin]] ([[folinic acid]]), and [[oxaliplatin]] | | | [[Fluorouracil]], [[leucovorin]] ([[folinic acid]]), and [[oxaliplatin]] |
| | [[Colorectal cancer]] | | | [[Colorectal cancer]] |
| | |- |
| | | '''HYPER-CVAD''' |
| | | Hyperfractionated cyclophosphamide, vincristine (Oncovin), doxorubicin (Adriamycin), dexamethasone ([[Decadron]]) |
| | | [[Burkitt's lymphoma]] |
| | |- |
| | | '''ICE''' |
| | | Ifosfamide, carboplatin, etopiside |
| | | Relapsed or primary refractory [[non-Hodgkin lymphoma]] |
| | |- |
| | | '''ICE-R'''' |
| | | ICE + [[rituximab]]| |
| | | Relapsed or primary refractory [[non-Hodgkin lymphoma]] |
| |- | | |- |
| | '''m-BACOD''' | | | '''m-BACOD''' |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic:
There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Chemotherapy regimens are often identified with acronyms, identifying the agents used in combination. Unfortunately, the letters used are not consistent across regimens, and in some cases (for example, "BEACOPP") the same letter is used to represent two different treatments. Because of this, there is not a naming standard for chemotherapy regimens, and this page merely represents commonly used conventions.
The term "Induction regimens" refers to a chemotherapy regimen which is used for the initial treatment of a disease.
| Name |
Components |
Example of uses, and other notes
|
| ABVD
|
Adriamycin, bleomycin, vinblastine, dacarbazine
|
Hodgkin's lymphoma
|
| AC
|
Adriamycin/Doxorubicin, Cyclophosphamide
|
Breast cancer
|
| BEACOPP
|
Bleomycin, etoposide, Adriamycin (doxorubicin), cyclophosphamide, Oncovin (vincristine), procarbazine, prednisone
|
Hodgkin's lymphoma
|
| BEP
|
Bleomycin, etoposide, platinum (cisplatin)
|
Testicular cancer, germ cell tumors
|
| CAF
|
Cyclophosphamide, Adriamycin/Doxorubicin, 5-FU/Fluorouracil
|
Breast cancer
|
| CAV
|
Cyclophosphamide, Adriamycin/Doxorubicin, Vincristine
|
Lung cancer
|
| CHOP
|
Cyclophosphamide, doxorubicin (hydroxydoxorubicin), vincristine (Oncovin), prednisone
|
Non-Hodgkin lymphoma
|
| CHOP-R
|
CHOP + rituximab
|
B cell non-Hodgkin lymphoma
|
| COP or CVP
|
Cyclophosphamide, vincristine (Oncovin), and prednisone
|
Non-Hodgkin lymphoma in patients with history of cardiovascular disease
|
| CMF
|
Cyclophosphamide, Methotrexate, and 5-Fluorouracil
|
Breast Cancer
|
| COPP
|
Cyclophosphamide, Oncovin (vincristine), procarbazine and prednisone
|
Non-Hodgkin lymphoma
|
| DA-EPOCH
|
Dose-adjusted Etopiside, prednisone, vincristine (Oncovin), Cyclophosphamide and doxorubicin
|
Newly diagnosed, aggressive non-Hodgkin lymphoma
|
| DHAP'
|
Dexamethasone, cytarabine (high-dose ARA-C), cisplatin
|
Recurrent or refractory non-Hodgkin lymphoma
|
| EC
|
Epirubicin, Cyclophosphamide
|
Breast cancer
|
| ECF
|
Epirubicin, cisplatin, fluorouracil
|
Gastric cancer and oesophageal cancer
|
| ESHAP
|
Etopiside, methylprednisolone (Solu-medrol), cytarabine (ARA-C), cisplatin
|
Relapsed or refractory non-Hodgkin lymphoma
|
| FN-D
|
Fludarabine, mitoxantrone (Novantrone), dexamethasone
|
Recurrent or refractory indolent non-Hodgkin lymphoma
|
| FOLFOX
|
Fluorouracil, leucovorin (folinic acid), and oxaliplatin
|
Colorectal cancer
|
| HYPER-CVAD
|
Hyperfractionated cyclophosphamide, vincristine (Oncovin), doxorubicin (Adriamycin), dexamethasone (Decadron)
|
Burkitt's lymphoma
|
| ICE
|
Ifosfamide, carboplatin, etopiside
|
Relapsed or primary refractory non-Hodgkin lymphoma
|
| ICE-R'
|
ICE + rituximab|
|
Relapsed or primary refractory non-Hodgkin lymphoma
|
| m-BACOD
|
Methotrexate, bleomycin, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), dexamethasone (Decadron)
|
Non-Hodgkin lymphoma
|
| MACOP-B
|
Methotrexate, leucovorin, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), prednisone, bleomycin
|
Non-Hodgkin lymphoma
|
| MOPP
|
Mechlorethamine, vincristine (oncovin), procarbazine, prednisone
|
Hodgkin's lymphoma
|
| PCV
|
Procarbazine, lomustine (CCNU), vincristine
|
Brain tumors
|
| ProMACE-MOPP
|
Methotrexate, doxorubicin (Adriamycin), cyclophosphamide, etoposide + MOPP
|
Non-Hodgkin lymphoma
|
| ProMACE-CytaBOM
|
Prednisone, doxorubicin (adriamycin), cyclophosphamide, etoposide, cytarabine, bleomycin, vincristine (Oncovin), methotrexate, leucovorin
|
Non-Hodgkin lymphoma
|
| R-FCM
|
Rituximab, fludarabine, cyclophosphamide, mitoxantrone
|
B cell non-Hodgkin lymphoma
|
| Stanford V
|
Doxorubicin (Adriamycin), mechlorethamine, bleomycin, vinblastine, vincristine (Oncovin), etoposide (VP-16), prednisone
|
Hodgkin's lymphoma
|
| Thal/Dex
|
Thalidomide, dexamethasone
|
Multiple myeloma
|
| VAD
|
Vincristine, Adriamycin (doxorubicin), dexamethasone
|
Multiple myeloma
|
See also
External links
Template:Chemotherapeutic Agents
Template:SIB
Template:WS